Cargando…
Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats
The use of cell therapies has recently increased for the treatment of pulmonary diseases. Mesenchymal stem/stromal cells (MSCs) and alveolar type II cells (ATII) are the main cell-based therapies used for the treatment of acute respiratory distress syndrome (ARDS). Many pre-clinical studies have sho...
Autores principales: | Guillamat-Prats, Raquel, Camprubí-Rimblas, Marta, Puig, Ferranda, Herrero, Raquel, Tantinyà, Neus, Serrano-Mollar, Anna, Artigas, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464506/ https://www.ncbi.nlm.nih.gov/pubmed/32751857 http://dx.doi.org/10.3390/cells9081816 |
Ejemplares similares
-
Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats
por: Camprubí‐Rimblas, Marta, et al.
Publicado: (2020) -
Effect of the alveolar type ii cells transplantation for the treatment of acute lung injury
por: Guillamat-Prats, R, et al.
Publicado: (2015) -
Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
por: Chimenti, Laura, et al.
Publicado: (2017) -
Comparison of direct and indirect models of early induced acute lung injury
por: Chimenti, Laura, et al.
Publicado: (2020) -
Methotrexate Ameliorates Systemic Inflammation and Septic Associated-Lung Damage in a Cecal Ligation and Puncture Septic Rat Model
por: Bringué, Josep, et al.
Publicado: (2021)